Top

Specialty Reagents & Molecular Tools Supply

Active

Federal

Response Deadline07/31/2026, 12:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Defense → Defense Advanced Research Projects AgcyView Agency

NAICS

325414 - Biological Product (except Diagnostic) ManufacturingView NAICS

Place of Performance

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJul 20

subcontract

Response DeadlineJul 31

Submission deadline

Response Deadline

07/31/2026, 12:00:00 PM UTCin 7 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Defense → Defense Advanced Research Projects Agcy

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → Defense Advanced Research Projects Agcy

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Supply of custom enzymes, modified tRNAs, synthetic peptides, or engineered ribosomes for use in protein editing experiments.

Similar Contracts

Same NAICS industry code

NAICS: 325414

New

Federal

Production of 4,000 Final Lateral Flow Strips

CDC Office Of Acquisition Services

POSTED

DEADLINE

Window and Door Supply (Materials Only)

POSTED

DEADLINE

Component Supply for Medical KitThe contract secures the supply of critical medical components including 20-gauge catheters, 17-gauge Tuohy needles, syringes, drapes, and antiseptic swabs to be integrated into epidural kits, ensuring standardized readiness for medical procedures. These items are essential for patient safety and procedural efficiency, requiring strict compliance with medical and quality standards for implantable and sterile disposable components. The solicitation is issued as a subcontract under NAICS code 325414, which classifies it within the pharmaceutical and medicinal product manufacturing sector, indicating the need for specialized production and packaging capabilities. The contract opportunity is managed by the Department of Defense through its Medical Supply Chain MD Surg FSF office, with performance required at JBER, Alaska, 99506-4400. Bidders must submit responses by July 28, 2026, with the solicitation posted on July 22, 2026. All suppliers are expected to meet exacting specifications for sterility, reliability, and consistency to support military medical readiness. No set-aside provisions are specified, meaning the contract is open to all eligible vendors regardless of business size or classification, and the sole point of access for bidding is through the DIBBS portal.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Medical Supply Kit Manufacturing and AssemblyThe contract requires the manufacture, assembly, and packaging of a sterile epidural anesthesia set comprising 29 components, including a catheter and Tuohy needle, all of which must meet stringent DLA standards and applicable medical device regulations. The product must be produced in a controlled environment to ensure sterility and compliance with federal medical device requirements, with final packaging and labeling adhering to specified technical and regulatory guidelines. The work must be completed and delivered according to strict timelines, with the place of performance designated at JBER, Alaska, and all materials and processes subject to inspection and validation by the contracting authority. This is a subcontract under the Department of Defense’s Medical Supply Chain, managed by the MEDICAL SUPPLY CHAIN MD SURG FSF, and is classified under NAICS code 325414 for medical supplies and equipment manufacturing. The solicitation was posted on July 22, 2026, with responses due by July 28, 2026, indicating a narrow window for submission. Interested parties must ensure full alignment with DLA specifications and be prepared to provide documentation demonstrating regulatory compliance, quality control procedures, and capability to deliver the complete kit as specified. Failure to meet any requirement may result in disqualification or noncompliance penalties.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Commercial Item Supplier for Medical Labels

Defense Logistics Agency

POSTED

DEADLINE

Medical Burn Wrap Supply and DeliveryThe contract entails the supply and delivery of sterile burn wrap containing silver, identified by NSN 6510015222173, to Fort Bliss, Texas, with strict adherence to all applicable shelf-life, packaging, labeling, and hazard communication standards to ensure safety and regulatory compliance. This is a subcontract under the Department of Defense, specifically managed by the Medical Supply Chain MD Surg FSF, and is categorized under NAICS code 325414 which corresponds to pharmaceutical and medicinal product manufacturing. All deliveries must meet the precise requirements set forth for sterile medical devices, including proper documentation, traceability, and compliance with federal and military specifications for medical supplies. The response deadline for submissions is July 28, 2026, and the product must be delivered to the designated location with zip code 79918-2527. The solicitation is publicly accessible via the DIBBS platform, and prospective vendors are expected to fulfill all performance conditions without deviation to maintain certification and contractual integrity.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supplier of Assorted Medical/Boxed Supplies (Unspecified CLIN 0002)The contract is a subcontract issued by the Department of Defense through the Medical Supply Chain FSH for the supply of unspecified medical items listed under CLIN 0002, described only as a single box with no further technical or itemized detail, suggesting it may represent a standardized medical kit or consumable package. The solicitation was posted on July 22, 2026, with a response deadline of July 29, 2026, and is tied to a NAICS code of 325414, which corresponds to pharmaceutical and medicine manufacturing, implying the contents are likely related to medical or pharmaceutical supplies. Performance is required at Joint Base Elmendorf-Richardson in Alaska, with the zip code 99506-4400, indicating the end-use location is a military medical or logistical facility. There is no information provided regarding the specific contents, required certifications, delivery conditions, or point of contact, and no set-aside status is designated, leaving the scope intentionally broad and reliant on supplier interpretation within regulatory and contractual guidelines.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Endodontic Gutta Percha SupplyThe contract is for the supply of endodontic gutta percha points that are color-coded and available in assorted sizes ranging from 45 to 80, each with a uniform length of 30 millimeters. The product must be packaged in boxes containing 120 units per box, adhering strictly to the specifications outlined in CLIN 0001. This subcontract is issued under the NAICS code 325414 and is managed by the Department of Defense through the MEDICAL SUPPLY CHAIN FSH organization. The place of performance is designated as JBER with the zip code 99506-4400. The solicitation was posted on July 22, 2026, and all responses must be submitted by the deadline of July 29, 2026. The full details and submission instructions can be accessed via the provided DIBBS portal link.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

TEST KIT, BACTERIA DThe contract is for the procurement of 25 units of the API 20 E bacterial identification test kit, designed for Enterobacteriaceae and other gram-negative rods, with one purchase unit equaling 25 kits. The product must be delivered within five days of contract award and must not have more than three months elapsed between its manufacture date and delivery to the government. It requires refrigeration at 2 to 8 degrees Celsius throughout storage and transport and is subject to a non-extendable shelf life of 18 months under the TYPE I (CODE K) classification. The item is regulated by the FDA, requiring pre-delivery referral for confirmation, and must be packaged and marked in accordance with Medical Marking Standard No. 1, superseding MIL-STD-129. Packaging must be commercial-grade, sealed, and robust enough to prevent damage during shipment, with exterior containers selected to ensure safe, low-cost delivery to the destination. The manufacturer is bioMérieux Inc, with part number 20100 and NSN 6550-01-507-3726. All packaging must comply with MIL-STD-2073-1E, and the item is subject to covered defense information requirements. The solicitation number is SPE2DS-26-T-261A, with a response deadline of July 28, 2026, and delivery is FOB destination with zero variance allowed in quantity.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Emergency Medical Supplies ProvisionThe contract pertains to the supply of essential medical materials including first aid kits, trauma dressings, personal protective equipment such as gloves, masks, and gowns, along with other medical consumables required for disaster response operations at Victoria Jubilee Hospital. These supplies are critical for ensuring immediate medical care during emergencies and must meet established standards for functionality, durability, and sterility to support effective response protocols. The procurement is structured as a subcontract under the broader emergency preparedness framework managed by the Kingston Public Hospital on behalf of the Government of Jamaica. Solicitation for this contract was posted on July 22, 2026, with a firm deadline for submissions set for July 27, 2026, at 8:00 PM, indicating a tight turnaround to address urgent operational needs. The North American Industry Classification System code 325414 identifies the sector as the manufacture of medical and surgical equipment and supplies, aligning with the nature of the requested products. All provisions are to be delivered to the designated facility in Jamaica, with no additional details on geographic distribution or logistics provided. Interested parties must submit proposals through the official electronic procurement portal linked in the contract data to be considered for award.

Kingston Public Hospital

POSTED

DEADLINE

Supply of Blood Components and ProductsThe contract entails the supply of whole blood and its derived components—including red blood cells, platelets, plasma, and cryoprecipitate—to Veterans Affairs medical centers, requiring full compliance with FDA and AABB standards throughout every stage of collection, testing, processing, and labeling. All activities must adhere to rigorous quality and safety protocols to ensure the integrity and suitability of blood products for patient transfusion, with strict attention to inventory management, chain of custody, and product traceability. The successful bidder must demonstrate consistent capacity to meet the VA’s operational demands while maintaining compliance with federal regulations and industry best practices. This subcontract is issued under the 252-NETWORK Contract Office 12 (36C255) of the Department of Veterans Affairs and falls under NAICS code 325414, which designates the manufacturing of biological products, excluding pharmaceuticals. The opportunity was posted on July 22, 2026, with a firm response deadline of August 21, 2026, at 5:00 p.m. The place of performance and specific delivery locations are not detailed in the provided data, but fulfillment is expected to support VA facilities nationwide. The contract requires a robust logistical and manufacturing infrastructure to handle the time-sensitive nature of blood component distribution while ensuring seamless integration into VA’s existing transfusion services.

252-NETWORK Contract Office 12 (36C252)

POSTED

DEADLINE

Purchase of new ChemiDoc™ MP Imaging system from BioRadThe contract is a non-competitive, sole-source procurement under FAR Part 13 Simplified Acquisition Procedures for the acquisition of a ChemiDoc™ MP Imaging System from Bio-Rad Laboratories, Inc., with an estimated value not to exceed $350,000. The system is intended for use by the TSB branch at the National Institutes of Health in Bethesda, Maryland, to advance research into thoracic malignancies by enabling high-resolution visualization and quantification of protein expression in both in vitro and in vivo models, supporting molecular profiling and biomarker discovery critical to understanding the causes of lung cancer, the leading cause of cancer-related deaths worldwide. The procurement is strictly limited to the delivery, installation, and operational setup of the specified instrument with no additional options, extensions, or follow-on work authorized. All submissions must be made electronically via email to the designated contracting officer, Vishnuvajjala Hanumanth Rao, referencing solicitation number 75N98026Q00856, and must include a technical proposal, cost-price proposal, period of performance, UEI, TIN, and business size certification. The offeror must be registered in SAM and comply with the NAICS code 325414 and its associated size standard of $34 million in average annual receipts. No formal evaluation factors, weights, or adjectival ratings are defined due to the simplified, non-competitive nature of the acquisition, which relies solely on responsiveness and responsibility of the sole offeror. Place of performance is Bethesda, Maryland, with no specific packaging, marking, inspection criteria, or FOB terms detailed in the documentation, indicating the instrument is treated as a commercial off-the-shelf item. No security clearances, key personnel requirements, OCI provisions, or special contractual clauses are imposed, and the contract will be administered under the contracting office located at 6701 Rockledge Drive, Bethesda, MD 20817, with no designated COR, COTR, or PCO identified beyond the primary point of contact.

National Institutes Of Health Olao

POSTED

2 days ago

DEADLINE

in 7 days

View Details

More opportunities from Department Of Defense → Defense Advanced Research Projects Agcy

Same awarding agency

NAICS: 541715

New

Federal

MXO Pitch Day 2026DARPA’s MXO Pitch Day 2026, identified by solicitation number DARPA-PA-26-07, is a targeted initiative designed to engage non-traditional performers, small businesses, and academic teams with no prior DARPA prime award experience in advancing foundational defense technologies. The program invites abstract submissions focused on innovative scientific discovery within thrust areas such as “a world beyond electronics” and “foundations beyond components,” with the goal of catalyzing breakthrough research that reduces technical uncertainty and opens new pathways for future development. Proposals are limited to five pages, must be submitted electronically through the DARPA BAAT portal by July 29, 2026, and are evaluated primarily on the clarity of the problem statement, the potential to redefine the state of the art, and the team’s vision and expertise—prioritizing technical merit over cost. Each submitted proposal must not exceed $500,000 in total cost and must be completed within a 12-month performance period, with no funding allowed for travel, publications, or subawards. Eligibility is strictly restricted to organizations and principal investigators who have never before received a DARPA award as a prime performer, and proposers must confirm active SAM.gov and PIEE registration, possess a valid CAGE code, and satisfy CMMC Level 1 self-assessment requirements. All submissions must be unclassified, and any use of AI tools in proposal preparation must be disclosed. Selected proposers will be invited to present in person at the MXO Pitch Day event in Chicago on November 2, 2026, where awards will be announced. The program operates under an Other Transaction authority, not traditional FAR-based contracting, and requires recipients to grant the U.S. government a nonexclusive, royalty-free license to all resulting intellectual property. Participation is barred for FFRDCs, UARCs, government entities, and organizations employing certain DARPA support contractors, and non-U.S. participants must comply with export control regulations. The solicitation emphasizes inclusivity and innovation over bureaucracy, creating a streamlined pathway for new entrants to contribute to national security research without prior defense contracting experience.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

MXO Office-wide Innovative Solutions OpeningThe Defense Advanced Research Projects Agency’s Multi X Office is seeking revolutionary research concepts through an open, rolling-call solicitation under DARPA-PS-26-115, targeting high-risk, high-reward innovations that exceed evolutionary improvements to current technologies. This solicitation, issued under the authority of 10 U.S.C. §§ 4021, 4022, and 4023, enables the use of Other Transactions for Research and Prototype agreements, allowing flexibility in contract structure and intellectual property arrangements. Proposals must align with one of three technical thrusts: developing novel materials and components beyond traditional CMOS foundations to ensure resilient and secure systems; establishing indigenous supply chains and tools for domestic design and production of critical technologies; or advancing new sensing, orienting, computing, and communicating modalities that redefine mission effects. The solicitation explicitly excludes research that merely refines existing capabilities and emphasizes transformative breakthroughs in science, components, or systems. All submissions must be made electronically via DARPA’s Broad Agency Announcement Tool, with an initial abstract required prior to any full proposal invitation, and abstracts must be submitted by April 23, 2027, with full proposals due by June 4, 2027, on a rolling basis following review. Abstracts must not exceed six pages, be unclassified or Controlled Unclassified Information, include a Rough Order of Magnitude cost estimate, and follow strict formatting guidelines. Full proposals must include two volumes—Technical and Management, and Price—along with additional supporting documents like the Proposal Summary Slide and Price Summary Spreadsheet, and require mandatory disclosure of any AI tools used in preparation. Proposers must be registered entities with a Unique Entity ID, CAGE code, and Taxpayer Identification Number, and must comply with NIST SP 800-171 rev 2 cybersecurity requirements unless the work qualifies as fundamental research, in which case safeguards apply only if the project scope changes. Government entities, FFRDCs, and UARCs face additional eligibility constraints, including demonstrating that the proposed work is not otherwise available through the private sector and providing legal authority documentation, with 15 U.S.C. § 3710a deemed insufficient. Foreign nationals and U.S. permanent residents participating in presentations must be covered by an eForm 60, and prime contractors are responsible for ensuring compliance across all subawardees. Evaluations prioritize overall scientific and technical merit, including innovation, feasibility, team expertise,

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Expedited Research Innovation System (ERIS)The Defense Advanced Research Projects Agency (DARPA), in partnership with The Applied Research Institute (ARI), is operating the Expedited Research Innovation System (ERIS), an open-call digital marketplace designed to identify, assess, and rapidly acquire groundbreaking technologies through Other Transaction Authority. This initiative, solicited under DARPA-PS-25-05, invites industry, academia, and individual innovators to submit video pitches that demonstrate novel or newly applied technologies capable of advancing national security priorities. Submissions are evaluated monthly, with deadlines at noon Eastern Time on the last day of each month, and must conform to strict technical specifications: a single 7-minute MP4 video in 720p resolution under 1 GB, using Rec709 or sRGB color space, and containing only a valid copyright notice. The video must clearly articulate the problem being solved, the current state of the art, the proposed advancement, team expertise, and potential defense or commercial impact. The solicitation does not include pricing, line items, or estimated contract values, as awards are negotiated post-assessment on a case-by-case basis, with no ceiling on award amounts. Evaluations are conducted by a peer review panel of government, industry, and academic subject matter experts under strict organizational conflict of interest protocols, including mandatory ethics training, non-disclosure agreements, and prohibitions on reviewing submissions in which assessors have financial interests. Technical merit is assessed using two weighted factors: advancement of the state of the art (40%) and team capability (60%), with awards determined by a trade-off approach based solely on technical excellence and not cost. Submissions must align with specified topic areas including AI/ML convergence with chemistry and biology, human performance optimization, sensing systems, resilience against chemical and biological threats, and advanced metrology, while excluding previously solicited areas such as elusive target tracking. All deliverables are digital; no physical packaging, labeling, or MIL-STD compliance is required. Eligible offerors must provide a unique entity identifier from SAM.gov and disclose small business status or nontraditional contractor affiliation, with foreign ownership requiring additional disclosure and possible mitigation. The entire process—submission, assessment, negotiation, and potential award—is conducted through the ERIS portal, enabling government organizations to quickly discover, review, and engage with breakthrough innovations without traditional competition.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Non-Optical Methods for High Speed Protein ControlDARPA’s Biological Technologies Office is seeking innovative solutions through the ERIS Marketplace to develop a new class of rapidly switchable, non-optogenetic protein domains capable of enabling real-time, massless control of cellular processes. The goal is to create a robust, modular molecular tool that responds to non-optical external signals such as magnetic fields or focused ultrasound, allowing precise regulation of protein function across cell membranes without relying on light or chemicals. Proposed solutions must achieve activation and deactivation kinetics of no more than two seconds, demonstrate reliable performance through at least 300 repetitive cycles in living cells, and function effectively in both split-protein dimerization and allosteric conformational configurations. This effort explicitly excludes any modifications or enhancements to existing optogenetic, light-based, or chemical systems. The anticipated contract value is $400,000 for a 12-month performance period, with awards being made on a rolling basis as solutions are evaluated, and the government reserves the right to issue awards before the December 8, 2026 submission deadline. Proposals must be submitted via the DARPA Connect ERIS Portal as a video that follows the required title format, or existing awardable solutions may be flagged for consideration by emailing ERIS@darpa.mil with specific subject and body requirements. Evaluation will focus on four core areas: a deep understanding of the problem space and current limitations in fields like sonogenetics and magnetogenetics, a significant technical leap in achieving rapid and repeatable protein control, demonstrated expertise in synthetic biology, protein engineering, and biophysics with a proven track record of quantitative in vivo characterization, and the potential of the solution to become a foundational tool in synthetic biology with broad applications in defense-relevant areas such as biomanufacturing, cell-based therapeutics, and biosensing. All submissions are subject to the ERIS assessment process, which serves as a mandatory pass/fail gate—only solutions deemed awardable by this process will be considered for BTO award. The procuring agency is the Department of Defense through DARPA’s Arlington, VA office, and all participants must comply with the ERIS Master Solicitation requirements available via SAM.gov.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

PerrseusThe Defense Advanced Research Projects Agency (DARPA) is seeking innovative proposals under solicitation DARPA-PS-26-127, titled Perrseus, to advance compact cold-atom devices and environmentally-decoupled ultra-high Q microelectromechanical (MEMS) and photonics systems through the development of microscale ultra-high-vacuum (µUHV) technologies. This effort is governed by an Other Transaction (OT) agreement under 10 U.S.C. § 4022, which allows DARPA to partner with nontraditional defense contractors and academic or commercial entities without being bound by standard Federal Acquisition Regulation (FAR) requirements. Proposals must be submitted by September 23, 2026, and successful applicants will enter into a flexible, milestone-driven agreement structured around either fixed-support or expenditure-based payment models, with funding tied to the achievement of defined technical objectives. The agreement will require adherence to specific administrative and technical obligations, including the submission of a Data Management Plan within 30 days of award, annual program reports, and a final executive summary documenting accomplishments and the value of the OT approach. Deliverables will be reviewed and accepted by the DARPA Agreement Officer’s Representative, with electronic invoicing and acceptance processed through the Wide Area Workflow (WAWF) system. The performer must comply with stringent cybersecurity and information safeguarding requirements, including the protection of Covered Defense Information as defined in the Controlled Unclassified Information (CUI) Registry, and must report any cyber incidents promptly. All contractors must maintain active registration in the System for Award Management (SAM), provide accurate payee data including Cage Code, UEI, and TIN, and certify compliance with federal laws regarding felony convictions and unpaid tax liabilities. The agreement prohibits the use of certain telecommunications and video surveillance equipment and requires that all subcontractors inherit key contractual provisions related to data rights, cybersecurity, export controls, and lobbying disclosures. Intellectual property rights are negotiated but generally remain with the performer, subject to government rights for national security purposes. The performer is obligated to safeguard all program-related data, requires prior written approval from DARPA before publicly releasing any findings, and must retain records for audit purposes for up to three years post-project. Additionally, if government funding exceeds $5 million, the Comptroller General of the United States is granted audit rights. Proposals are to be submitted via email, with the Data Management Plan uploaded to the DARPA Vault, and invention disclosures submitted through I-Edison. All activities

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Biosafety & Regulatory Compliance Support

Environmental Consulting Services

POSTED

DEADLINE

Protein Function Validation & Analytics Platform

Testing Laboratories and Services

POSTED

DEADLINE

In Vitro Organoid & Tissue System Modeling

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Co-Translational Protein Editing Systems

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Protein Splicing & Ligation Technology Development

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Protein ENGineering (PENG) Proposer DayThe Defense Advanced Research Projects Agency’s Defense Sciences Office is hosting a Proposers Day on August 10, 2026, in Arlington, Virginia, to introduce the Protein ENGineering (PENG) program, with a virtual webcast available for remote participation. Registration is mandatory for both in-person and virtual attendance, and the event aims to communicate the program’s vision, outline DARPA’s operational structure and milestones, and foster collaborations among industry, academia, and government entities with the necessary expertise and infrastructure. This gathering is designed to guide potential proposers in developing responsive research and development proposals aligned with the PENG program’s objectives. The official solicitation number for this initiative is DARPA-SN-26-102, published on July 20, 2026, with a response deadline of July 31, 2026. The program falls under the NAICS code 541715 for research and development in biotechnology. Primary point of contact for inquiries is the BAA Coordinator, reachable via PENG@darpa.mil, and the event is organized by the Department of Defense through DARPA’s office located in Arlington, Virginia. Interested parties are expected to review the details and register promptly to ensure participation in this critical pre-proposal engagement.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Non-Uniformity Correction (NUC) & Image Processing Algorithms

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

7 days ago

DEADLINE

in 21 days

View Details